Lunai Bioworks Inc.LNAI

時価総額
$3173.9万
PER
マルチオミクス解析とAI診断プラットフォームの新興企業。液体生検を含むマルチモーダル解析とOxford Nanopore採用のシーケンシングサービスを展開。GEDi Cubeを2024年2月13日に買収、CLIA/ISO認証ラボ設置計画。オランダを起点にEMEA・米国展開。
2012年
3月31日
2013年
3月31日
2014年
12月31日
2016年
6月30日
2017年
6月30日
2018年
6月30日
2019年
6月30日
2021年
6月30日
2022年
6月30日
2023年
6月30日
2024年
6月30日
NET LOSS-29,945-37,589-2,370,883-1,735,239-2,392,830471-18,016,480-26,723,607-113,433,392-39,684,056-80,650,172
Depreciation and amortization--45,20127,39514,528371,709123,535123,590113,496121,859
Change in fair value of contingent consideration--------3,048,0333-5
Loss on extinguishment of debt-----------1,303,578
Non-cash stock-based compensation expense----------5
Non-cash restricted shares issued for services rendered---------228,0005
Intangible asset impairment----------43
Goodwill impairment----------12
Amortization of discount on note payable--------296,505-297,212-348,621580,605
Insurance receivable-----471,641-108,005-119,831-342-1,594-461
Prepaid expenses/deposits----19,828138,841160,940-733,739-461,310-1,070,249-1,082,267
Accounts payable--162,950574,975-652,785119,575-29,946-272,318144
Other current liabilities-------30,00424,056-54,060-
Operating leases, net----------27,22411,284
Accrued expenses----------578,8095
NET CASH USED IN OPERATING ACTIVITIES-24,945-30,092-2,034,175-1,472,289--4,338,269-8,507,341-20,610,723-15,732,336-11,774,549-10,971,430
Notes receivable prior to acquisition----------1
Cash received from acquisition, net----------65,851
Purchase of property and equipment-----30,000716,66948,8925,15629,77470,430
NET CASH USED IN INVESTING ACTIVITIES-13,219-13,219-1,952,0341--575,732-716,669-48,892-5,156-29,774-1,260,179
Repayments of finance agreement----------870,073
Proceeds from exercise of warrants------682,056130,0002341,865
Proceeds from private placements-------5-43
Proceeds from issuance of promissory notes----------4
Proceeds from convertible notes payable----413,670-----4
NET CASH PROVIDED BY FINANCING ACTIVITIES38,50075,0007--176334511
 Effect of exchange rates on cash---------5,240-8,39560,141
NET INCREASE (DECREASE) IN CASH-------12-11,492,268-7,297,662-1,654,013
Interest------4389,22479,716352,33420,128
Income Taxes----64,003--3734--
Finance agreement entered into in exchange for prepaid assets-------607,250666,8751906,834
Conversion of note payable for issuance of preferred stock----------2
Note payable settled through non-cash exercise of warrants----------2
Debt discount related to notes payable----------339,342
Common shares issued upon acquisition----------136
Contingent consideration issued upon acquisition----------21
Common shares issued upon settlement of debt----------10
Earn out shares issued in settlement of contingent liability----------4
Options issued in settlement of debt----------489,000
Settlement of notes payable----------418,503